TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$13.16M2017: -$23.72M2018: $10.56M2019: -$36.37M2020: -$44.82M2021: -$30.17M2022: -$78.13M2023: -$75.26M2024: -$89.23M2025: -$152.91M-$152.91M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$152.91M-71.4%
2024-$89.23M-18.6%
2023-$75.26M+3.7%
2022-$78.13M-159.0%
2021-$30.17M+32.7%
2020-$44.82M-23.2%
2019-$36.37M-444.4%
2018$10.56M+144.5%
2017-$23.72M-80.3%
2016-$13.16M—